11/14/2024
4:47 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024
4:48 PM | 5AM Partners VII, LLC (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13G/A | |
10/24/2024
1:02 PM | BlackRock, Inc. (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13G | |
10/21/2024
3:19 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form RW | |
10/09/2024
11:15 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form EFFECT | |
10/09/2024
11:15 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form EFFECT | |
10/01/2024
7:00 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/01/2024
3:31 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
10/01/2024
3:36 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/18/2024
4:38 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
4:32 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Romano Steven J. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/12/2024
7:45 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Viridian, LLC (Filed by)
| Form SC 13D/A | |
08/08/2024
3:26 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
06/06/2024
7:00 AM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/28/2024
6:57 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:58 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Lawton Alison Frances (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:58 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
McGeorge Anne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:58 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
6:59 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Soteropoulos Paula (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:02 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Violin Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:03 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Garcia Marino (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:04 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Savitz Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:04 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Randhawa Simrat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:05 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Veness Adam M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
7:05 PM | CARR EDWARD (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/28/2024
4:24 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 424B3 | |
05/28/2024
4:20 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:20 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/09/2024
3:08 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:05 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form DEF 14A | |
04/11/2024
3:09 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form DEFA14A | |
04/11/2024
3:10 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form ARS | |
04/01/2024
5:34 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
04/01/2024
5:21 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/27/2024
11:15 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form EFFECT | |
03/21/2024
4:02 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-1/A | |
03/21/2024
4:10 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/02/2024
3:32 PM | BCLS Fund III Investments, LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13G | |
01/31/2024
11:11 AM | Avidity Partners Management LP (Filed by)
Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
| Form SC 13D | |
01/24/2024
6:02 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Fairmount Funds Management LLC (Reporting)
Harwin Peter Evan (Reporting)
Kiselak Tomas (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
6:04 PM | Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
MOULDER LEON O JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
This Bull Market Indicator called NVDA at $116 (Ad) Every now and again we find an investment idea so incredible we can’t help but share.
And today is one of those rare days…
Except, today we won't be giving you insight on any one particular stock…
But rather, insight on a revolutionary new stock picking indicator…
In fact, within the last year, this indicator has become famous for a multitude of reasons…
But one of the biggest was because of the buy signal it issued on October 18th, 2022.
In fact, on that very day, it said to buy NVDA at $116.37…
Anyone who did would be sitting on a tremendously large return today…
But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run… All you have to do is follow this link here |
01/24/2024
5:55 PM | Avidity Partners Management LLC (0001993910) (Reporting)
Avidity Partners Management LP (Reporting)
Dianthus Therapeutics, Inc. /DE/ (Issuer)
Dianthus Therapeutics (Issuer)
Gregory Michael David (Reporting)
Meng Lei (Reporting)
Witzke David Roy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/24/2024
4:26 PM | Dianthus Therapeutics, Inc. /DE/ (Subject)
Dianthus Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
| Form SC 13D/A | |
01/22/2024
6:34 AM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:02 AM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2023
4:08 PM | Dianthus Therapeutics, Inc. /DE/ (Filer)
Dianthus Therapeutics (Filer)
| Form S-1/A | |
